Divi's Labs Q3 results: Net profit rises 31% to Rs 471 cr
The company had posted a net profit of Rs 359.09 crore for the corresponding period of the previous fiscal, Divi's Laboratories said in a filing to the BSE.
By PTI |
TOI.in
Drug firm Divi's Laboratories on Saturday reported a 31.05 net profit of Rs 470.62 crore for the quarter ended December 2020, on account of robust sales.
The company had posted a net profit of Rs 359.09 crore for the corresponding period of the previous fiscal, Divi's Laboratories said in a filing to the BSE.
Total income of the company on a consolidated basis stood at Rs 1,720.76 crore for the quarter under consideration.
It was Rs 1,437.93 crore for the same period a year ago, it added.
The company has been able to have normalised operations during the quarter, Divi's Laboratories said.
The company had posted a net profit of Rs 359.09 crore for the corresponding period of the previous fiscal, Divi's Laboratories said in a filing to the BSE.
Total income of the company on a consolidated basis stood at Rs 1,720.76 crore for the quarter under consideration.
It was Rs 1,437.93 crore for the same period a year ago, it added.
The company has been able to have normalised operations during the quarter, Divi's Laboratories said.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
